Document

{"links":{"self":"https://clientapi.gcs-web.com/data/33381f6d-8eaa-46ae-8c63-71b3672717c2/filings/25676/html"},"meta":{"executionDate":"2026-07-16T05:45:02","cmsDomain":"https://bradyid.gcs-web.com"},"data":"\n\n\t\n\t\t\n\t\t\n\t\tDocument\n\t\n\t\n

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 10-Q



þ	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended April 30, 2017



¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Transition Period from to

Commission File Number 1-14959

BRADY CORPORATION

(Exact name of registrant as specified in its charter)



Wisconsin		39-0178960
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)



6555 West Good Hope Road, Milwaukee, Wisconsin		53223
(Address of principal executive offices)		(Zip Code)

(414) 358-6600

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,\" and \"emerging growth company\" in Rule 12b-2 of the Exchange Act.



Large accelerated filer	þ	Accelerated filer	¨	Emerging growth company	¨
Non-accelerated filer	¨	Smaller reporting company	¨
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.	¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No þ

APPLICABLE ONLY TO CORPORATE ISSUERS

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

As of May 23, 2017, there were 47,758,478 outstanding shares of Class A Nonvoting Common Stock and 3,538,628 shares of Class B Voting Common Stock. The Class B Voting Common Stock, all of which is held by affiliates of the Registrant, is the only voting stock.

Table of Contents

FORM 10-Q

BRADY CORPORATION

INDEX




	Page
PART I. Financial Information	3
Item 1. Financial Statements (Unaudited)	3
Condensed Consolidated Balance Sheets	3
Condensed Consolidated Statements of Earnings	4
Condensed Consolidated Statements of Comprehensive Income	5
Condensed Consolidated Statements of Cash Flows	6
Notes to Condensed Consolidated Financial Statements	7
Item 2. Management’s Discussion and Analysis of Results of Operations and Financial Condition	18
Item 3. Quantitative and Qualitative Disclosures About Market Risk	26
Item 4. Controls and Procedures	26
PART II. Other Information	27
Item 6. Exhibits	27
Signatures	28

Table of Contents

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

BRADY CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(Dollars in Thousands, Unaudited)



	April 30, 2017		July 31, 2016
ASSETS
Current assets:
Cash and cash equivalents	$	129,077			$	141,228
Accounts receivable—net	145,755			147,333
Inventories:
Finished products	61,025			64,313
Work-in-process	17,326			16,678
Raw materials and supplies	19,126			18,436
Total inventories	97,477			99,427
Prepaid expenses and other current assets	20,343			19,436
Total current assets	392,652			407,424
Other assets:
Goodwill	425,935			429,871
Other intangible assets	54,107			59,806
Deferred income taxes	26,228			27,238
Other	18,152			17,181
Property, plant and equipment:
Cost:
Land	7,271			5,809
Buildings and improvements	95,662			95,355
Machinery and equipment	257,465			256,549
Construction in progress	4,362			2,842
	364,760			360,555
Less accumulated depreciation	268,586			258,111
Property, plant and equipment—net	96,174			102,444
Total	$	1,013,248			$	1,043,964
LIABILITIES AND STOCKHOLDERS’ INVESTMENT
Current liabilities:
Notes payable	$	4,072			$	4,928
Accounts payable	60,144			62,245
Wages and amounts withheld from employees	45,079			45,998
Taxes, other than income taxes	7,109			7,403
Accrued income taxes	2,706			6,136
Other current liabilities	39,022			40,017
Total current liabilities	158,132			166,727
Long-term obligations, less current maturities	133,894			211,982
Other liabilities	57,159			61,657
Total liabilities	349,185			440,366
Stockholders’ investment:
Class A nonvoting common stock—Issued 51,261,487 and 51,261,487 shares, respectively and outstanding 47,738,671 and 46,920,974 shares, respectively	513			513
Class B voting common stock—Issued and outstanding, 3,538,628 shares	35			35
Additional paid-in capital	321,936			317,001
Earnings retained in the business	492,411			453,371
Treasury stock—3,522,816 and 4,340,513 shares, respectively of Class A nonvoting common stock, at cost	(87,493	)		(108,714	)
Accumulated other comprehensive loss	(63,339	)		(54,745	)
Other	—			(3,863	)
Total stockholders’ investment	664,063			603,598
Total	$	1,013,248			$	1,043,964

See Notes to Condensed Consolidated Financial Statements.

Table of Contents

BRADY CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS

(Dollars in Thousands, Except Per Share Amounts, Unaudited)



	Three months ended April 30,		Nine months ended April 30,
	2017		2016		2017		2016
Net sales	$	275,927			$	286,816			$	824,104		$	838,519
Cost of products sold	136,018			141,373			409,679			420,835
Gross margin	139,909			145,443			414,425			417,684
Operating expenses:
Research and development	9,950			8,865			28,577			26,531
Selling, general and administrative	98,409			105,794			291,128			306,678
Total operating expenses	108,359			114,659			319,705			333,209
Operating income	31,550			30,784			94,720			84,475
Other income (expense):
Investment and other income (expense)	453			721			560			(1,030	)
Interest expense	(1,375	)		(1,838	)		(4,565	)		(6,119	)
Earnings before income taxes	30,628			29,667			90,715			77,326
Income tax expense	8,075			8,686			20,312			22,352
Net earnings	$	22,553			$	20,981			$	70,403		$	54,974
Net earnings per Class A Nonvoting Common Share:
Basic	$	0.44			$	0.42			$	1.38		$	1.09
Diluted	$	0.43			$	0.42			$	1.36		$	1.08
Dividends	$	0.21			$	0.20			$	0.62		$	0.61
Net earnings per Class B Voting Common Share:
Basic	$	0.44			$	0.42			$	1.37		$	1.07
Diluted	$	0.43			$	0.42			$	1.34		$	1.07
Dividends	$	0.21			$	0.20			$	0.60		$	0.59
Weighted average common shares outstanding (in thousands):
Basic	51,227			50,251			50,972			50,602
Diluted	52,201			50,505			51,882			50,747

See Notes to Condensed Consolidated Financial Statements.

Table of Contents

BRADY CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(Dollars in Thousands, Unaudited)



	Three months ended April 30,		Nine months ended April 30,
	2017		2016		2017		2016
Net earnings	$	22,553			$	20,981			$	70,403		$	54,974
Other comprehensive loss:
Foreign currency translation adjustments	4,819			24,889			(11,729	)		10,943

Net investment hedge translation adjustments	(2,072	)		(3,733	)		3,376			(191	)

Long-term intercompany loan translation adjustments	821			(2,321	)		543			(6,141	)

Cash flow hedges:
Net gain (loss) recognized in other comprehensive loss	508			(167	)		402			(729	)
Reclassification adjustment for losses (gains) included in net earnings	114			169			530			(174	)
	622			2			932			(903	)
Pension and other post-retirement benefits:
Net (loss) gain recognized in other comprehensive loss	—			(2	)		72			(2	)
Actuarial gain amortization	(136	)		(161	)		(408	)		(484	)
Prior service credit amortization	—			—			—			(1,035	)
	(136	)		(163	)		(336	)		(1,521	)

Other comprehensive income (loss), before tax	4,054			18,674			(7,214	)		2,187
Income tax benefit (expense) related to items of other comprehensive income (loss)	821			1,313			(1,380	)		478
Other comprehensive income (loss), net of tax	4,875			19,987			(8,594	)		2,665
Comprehensive income	$	27,428			$	40,968			$	61,809		$	57,639

See Notes to Condensed Consolidated Financial Statements.

Table of Contents

BRADY CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Dollars in Thousands, Unaudited)



	Nine months ended April 30,
	2017		2016
Operating activities:
Net earnings	$	70,403			$	54,974
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	20,789			24,896
Stock-based compensation expense	7,445			6,247
Deferred income taxes	(2,707	)		3,169
Changes in operating assets and liabilities:
Accounts receivable	(931	)		4,679
Inventories	666			4,556
Prepaid expenses and other assets	(1,987	)		(734	)
Accounts payable and other liabilities	754			3,432
Income taxes	(3,270	)		(2,669	)
Net cash provided by operating activities	91,162			98,550

Investing activities:
Purchases of property, plant and equipment	(10,856	)		(7,468	)
Other	38			1,987
Net cash used in investing activities	(10,818	)		(5,481	)

Financing activities:
Payment of dividends	(31,362	)		(30,603	)
Proceeds from exercise of stock options	18,674			663
Purchases of treasury stock	—			(23,552	)
(Repayments) proceeds from borrowing on credit facilities	(60,415	)		28,819
Principal payments on debt	(16,371	)		(42,514	)
Debt issuance costs	—			(803	)
Income tax on equity-based compensation, and other	(512	)		(1,238	)
Net cash used in financing activities	(89,986	)		(69,228	)

Effect of exchange rate changes on cash	(2,509	)		3,263

Net (decrease) increase in cash and cash equivalents	(12,151	)		27,104
Cash and cash equivalents, beginning of period	141,228			114,492

Cash and cash equivalents, end of period	$	129,077			$	141,596

See Notes to Condensed Consolidated Financial Statements

Table of Contents

BRADY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Nine Months Ended April 30, 2017

(Unaudited)

(In thousands, except share and per share amounts)

NOTE A — Basis of Presentation

The condensed consolidated financial statements included herein have been prepared by Brady Corporation and subsidiaries (the \"Company,\" \"Brady,\" \"we,\" or \"our\") without audit, pursuant to the rules and regulations of the Securities and Exchange Commission. In the opinion of the Company, the foregoing statements contain all adjustments, consisting only of normal recurring adjustments necessary to present fairly the financial position of the Company as of April 30, 2017 and July 31, 2016, its results of operations and comprehensive income for the three and nine months ended April 30, 2017 and 2016, and cash flows for the nine months ended April 30, 2017 and 2016. The consolidated balance sheet as of July 31, 2016, has been derived from the audited consolidated financial statements as of that date. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts therein. Due to the inherent uncertainty involved in making estimates, actual results in future periods may differ from the estimates.

Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been omitted pursuant to rules and regulations of the Securities and Exchange Commission. Accordingly, the condensed consolidated financial statements do not include all of the information and footnotes required by GAAP for complete financial statement presentation. It is suggested that these condensed consolidated financial statements be read in conjunction with the consolidated financial statements and the notes thereto included in the Company’s annual report on Form 10-K for the year ended July 31, 2016.

NOTE B — Goodwill and Other Intangible Assets

Changes in the carrying amount of goodwill for the nine months ended April 30, 2017, were as follows:



	IDS		WPS		Total
Balance as of July 31, 2016	$	384,529			$	45,342			$	429,871
Translation adjustments	(4,298	)		362			(3,936	)
Realignment of businesses between segments	2,490			(2,490	)		—
Balance as of April 30, 2017	$	382,721			$	43,214			$	425,935

Goodwill at April 30, 2017 and July 31, 2016, included $118,637 and $209,392 of accumulated impairment losses within the Identification Solutions (\"IDS\") and Workplace Safety (\"WPS\") segments, respectively, for a total of $328,029. There were no impairment charges recorded during the nine months ended April 30, 2017.

As further discussed in Note E - Segment Information, the Company realigned certain businesses between the WPS and IDS reportable segments effective August 1, 2016. In accordance with ASC 350, \"Intangibles - Goodwill and Other,\" the Company completed a relative fair value calculation of the businesses that were realigned and moved the corresponding goodwill balance of $2,490 between the two reportable segments.

Table of Contents

Other intangible assets include patents, trademarks, customer relationships, non-compete agreements and other intangible assets with finite lives being amortized in accordance with the accounting guidance for other intangible assets. The Company also has unamortized indefinite-lived trademarks that are classified as other intangible assets. The net book value of these assets was as follows:



	April 30, 2017	July 31, 2016
	Weighted Average Amortization Period (Years)	Gross Carrying Amount		Accumulated Amortization		Net Book Value		Weighted Average Amortization Period (Years)	Gross Carrying Amount		Accumulated Amortization		Net Book Value
Amortized other intangible assets:
Patents	5	$	12,337			$	(11,410	)	$	927			5	$	12,252		$	(11,063	)	$	1,189
Trademarks and other	5	14,328			(13,864	)		464		5		14,359		(13,709	)	650
Customer relationships	7	134,618			(104,496	)		30,122		7		135,795		(100,830	)	34,965
Non-compete agreements and other	4	9,091			(9,091	)		—		4		9,153		(9,142	)	11
Unamortized other intangible assets:
Trademarks	N/A	22,594			—			22,594		N/A		22,991		—		22,991
Total		$	192,968			$	(138,861	)	$	54,107				$	194,550		$	(134,744	)	$	59,806

The decrease in the gross carrying amount of other intangible assets as of April 30, 2017, compared to July 31, 2016, was primarily due to the effect of currency fluctuations during the nine-month period.

Amortization expense on intangible assets was $1,766 and $1,838 for the three months ended April 30, 2017 and 2016, respectively, and $5,349 and $7,066 for the nine months ended April 30, 2017 and 2016, respectively. The amortization over each of the next five fiscal years is projected to be $6,869, $6,158, $5,936, $5,431 and $5,385 for the fiscal years ending July 31, 2017, 2018, 2019, 2020 and 2021, respectively.

NOTE C — Other Comprehensive Loss

Other comprehensive loss consists of foreign currency translation adjustments, unrealized gains and losses from cash flow hedges and net investment hedges, and the unamortized gain on post-retirement plans, net of their related tax effects.

The following table illustrates the changes in the balances of each component of accumulated other comprehensive loss, net of tax, for the nine months ended April 30, 2017:



	Unrealized (loss) gain on cash flow hedges		Unamortized gain on post-retirement plans		Foreign currency translation adjustments		Accumulated other comprehensive loss
Beginning balance, July 31, 2016	$	(857	)		$	2,236			$	(56,124	)	$	(54,745	)
Other comprehensive income (loss) before reclassification	563			72			(9,144	)		(8,509	)
Amounts reclassified from accumulated other comprehensive loss	323			(408	)		—			(85	)
Ending balance, April 30, 2017	$	29			$	1,900			$	(65,268	)	$	(63,339	)

The increase in accumulated other comprehensive loss as of April 30, 2017, compared to July 31, 2016, was primarily due to the appreciation of the U.S. dollar against certain other currencies during the nine-month period. The foreign currency translation adjustments column in the table above includes the impact of foreign currency translation, foreign currency translation on intercompany notes, and the settlements of net investment hedges, net of tax. Of the total $85 reclassified from accumulated other comprehensive loss, the $323 loss on cash flow hedges was reclassified into cost of products sold, and the $408 gain on post-retirement plans was reclassified into selling, general and administrative expenses (\"SG&A\") on the condensed consolidated statement of earnings for the nine months ended April 30, 2017.

The changes in accumulated other comprehensive loss by component, net of tax, for the nine months ended April 30, 2016, were as follows:

Table of Contents



	Unrealized gain (loss) on cash flow hedges		Unamortized gain on post-retirement plans		Foreign currency translation adjustments		Accumulated other comprehensive loss
Beginning balance, July 31, 2015	$	9			$	3,438		$	(48,481	)	$	(45,034	)
Other comprehensive (loss) income before reclassification	(368	)		(2	)		4,634		4,264
Amounts reclassified from accumulated other comprehensive loss	(106	)		(1,520	)		—		(1,626	)
Ending balance, April 30, 2016	$	(465	)		$	1,916		$	(43,847	)	$	(42,396	)

The decrease in accumulated other comprehensive loss as of April 30, 2016, compared to July 31, 2015, was primarily due to the depreciation of the U.S. dollar against certain other currencies during the nine-month period. The foreign currency translation adjustments column in the table above includes the impact of foreign currency translation, foreign currency translation on intercompany notes, and the settlements of net investment hedges, net of tax. Of the total $1,626 reclassified from accumulated other comprehensive loss, the $106 gain on cash flow hedges was reclassified into cost of products sold, and the $1,520 gain on post-retirement plans was reclassified into SG&A on the condensed consolidated statement of earnings for the nine months ended April 30, 2016.

The following table illustrates the income tax expense on the components of other comprehensive loss for the three and nine months ended April 30, 2017 and 2016:



	Three months ended April 30,		Nine months ended April 30,
	2017		2016		2017		2016
Income tax benefit (expense) related to items of other comprehensive income (loss):
Net investment hedge translation adjustments	$	752			$	1,456			$	(1,373	)	$	75
Cash flow hedges	90			(126	)		(46	)		428
Pension and other post-retirement benefits	—			25			—			27
Other income tax adjustments and currency translation	(21	)		(42	)		39			(52	)
Income tax benefit (expense) related to items of other comprehensive income (loss)	$	821			$	1,313			$	(1,380	)	$	478

Table of Contents

NOTE D — Net Earnings per Common Share

Reconciliations of the numerator and denominator of the basic and diluted per share computations for the Company’s Class A and Class B common stock are summarized as follows:



	Three months ended April 30,		Nine months ended April 30,
	2017		2016		2017		2016
Numerator: (in thousands)
Earnings (Numerator for basic and diluted Class A Nonvoting Common Share)	$	22,553			$	20,981			$	70,403		$	54,974
Less:
Preferential dividends	—			—			(788	)		(783	)
Preferential dividends on dilutive stock options	—			—			(14	)		(1	)
Numerator for basic and diluted earnings per Class B Voting Common Share	$	22,553			$	20,981			$	69,601		$	54,190
Denominator: (in thousands)
Denominator for basic earnings per share for both Class A and Class B	51,227			50,251			50,972			50,602
Plus: Effect of dilutive stock options and restricted stock units	974			254			910			145
Denominator for diluted earnings per share for both Class A and Class B	52,201			50,505			51,882			50,747
Net earnings per Class A Nonvoting Common Share:
Basic	$	0.44			$	0.42			$	1.38		$	1.09
Diluted	$	0.43			$	0.42			$	1.36		$	1.08
Net earnings per Class B Voting Common Share:
Basic	$	0.44			$	0.42			$	1.37		$	1.07
Diluted	$	0.43			$	0.42			$	1.34		$	1.07

Options to purchase 577,557 and 2,480,000 shares of Class A Nonvoting Common Stock for the three months ended April 30, 2017 and 2016, respectively, and 705,859 and 3,525,000 shares for the nine months ended April 30, 2017 and 2016, respectively, were not included in the computation of diluted net earnings or loss per share because the option exercise price was greater than the average market price of the common shares and, therefore, the effect would have been anti-dilutive.

NOTE E — Segment Information

The Company is organized and managed on a global basis within three operating segments, Identification Solutions (\"IDS\"), Workplace Safety (\"WPS\"), and People Identification (\"People ID\"), which aggregate into two reportable segments that are organized around businesses with consistent products and services: IDS and WPS. The Identification Solutions and People ID operating segments aggregate into the IDS reporting segment, while the WPS reporting segment is comprised solely of the Workplace Safety operating segment.

Effective August 1, 2016, the Company changed its internal measure of segment profit and loss that is reported to the chief operating decision maker for purposes of making decisions about allocating resources to the segment and assessing its performance. Prior to August 1, 2016, certain administrative costs were excluded from the measure of segment profit and loss. Effective August 1, 2016, a portion of these administrative costs have been included within the IDS and WPS segments, which includes the cost of finance, information technology, human resources, and certain other administrative costs. Interest expense, investment and other income (expense), income tax expense, and certain corporate administrative expenses continue to be excluded when evaluating segment performance.

Also effective August 1, 2016, the Company realigned certain businesses between the WPS and IDS reportable segments, resulting in increased revenues and segment profit in the IDS segment and equal and offsetting declines in revenues and segment profit in the WPS segment. The Company's accompanying segment information has been restated to reflect the change in measurement of segment profit and loss and the realignment of businesses.

Table of Contents

The following is a summary of segment information for the three and nine months ended April 30, 2017 and 2016:



	Three months ended April 30,		Nine months ended April 30,
	2017		2016		2017		2016
Sales to External Customers
ID Solutions	$	196,880			$	201,482		$	589,106	$	592,282
Workplace Safety	79,047			85,334			234,998		246,237
Total Company	$	275,927			$	286,816		$	824,104	$	838,519
Segment Profit
ID Solutions	$	32,633			$	31,898		$	94,676	$	80,385
Workplace Safety	5,120			6,012			17,615		21,690
Total Company	$	37,753			$	37,910		$	112,291	$	102,075

The following is a reconciliation of segment profit to earnings before income taxes for the three and nine months ended April 30, 2017 and 2016:



	Three months ended April 30,		Nine months ended April 30,
	2017		2016		2017		2016
Total profit from reportable segments	$	37,753			$	37,910			$	112,291		$	102,075
Unallocated amounts:
Administrative costs	(6,203	)		(7,126	)		(17,571	)		(17,600	)
Investment and other income (expense)	453			721			560			(1,030	)
Interest expense	(1,375	)		(1,838	)		(4,565	)		(6,119	)
Earnings before income taxes	$	30,628			$	29,667			$	90,715		$	77,326

NOTE F – Stock-Based Compensation

The Company has an incentive stock plan under which the Board of Directors may grant nonqualified stock options to purchase shares of Class A Nonvoting Common Stock, restricted stock units (\"RSUs\"), or restricted and unrestricted shares of Class A Nonvoting Common Stock to employees and non-employee directors. Certain awards may be subject to pre-established performance goals.

The options issued under the plan have an exercise price equal to the fair market value of the underlying stock at the date of grant and generally vest over a three-year service period, with one-third becoming exercisable one year after the grant date and one-third additional in each of the succeeding two years. Options issued under the plan, referred to herein as “service-based” stock options, generally expire 10 years from the date of grant.

Restricted and unrestricted shares and RSUs issued under the plan have a grant date fair value equal to the fair market value of the underlying stock at the date of grant. Shares issued under the plan are referred to herein as either \"service-based\" or \"performance-based\" restricted shares and RSUs. The service-based RSUs granted under the plan generally vest over a three-year service period, with one-third becoming exercisable one year after the grant date and one-third additional in each of the succeeding two years. The performance-based RSUs granted under the plan vest at the end of a three-year service period provided specified company financial performance metrics are met.

As of April 30, 2017, the Company has reserved 3,596,805 shares of Class A Nonvoting Common Stock for outstanding stock options, RSUs, and restricted shares and 4,478,958 shares of Class A Nonvoting Common Stock remain for future issuance of stock options, RSUs, and restricted and unrestricted shares under the plan. The Company uses treasury stock or will issue new Class A Nonvoting Common Stock to deliver shares under the plan.

The Company recognizes the compensation cost of all share-based awards at the time it is deemed probable the award will vest. This cost is recognized on a straight-line basis over the vesting period of the award. If it is determined that it is unlikely the award will vest, the expense recognized to date for the award is reversed in the period in which this is evident and the remaining expense is not recorded. Total stock-based compensation expense recognized by the Company during the three months ended April 30, 2017 and 2016, was $2,051 ($1,272 net of taxes) and $1,678 ($1,040 net of taxes), respectively. Expense recognized during the nine months ended April 30, 2017 and 2016, was $7,445 ($4,616 net of taxes) and $6,247 ($3,873 net of taxes), respectively.

Table of Contents

As of April 30, 2017, total unrecognized compensation cost related to stock-based compensation awards was $15,840 pre-tax, net of estimated forfeitures, which the Company expects to recognize over a weighted-average period of 2.0 years.

The Company has estimated the grant date fair value of its service-based stock option awards granted during the nine months ended April 30, 2017 and 2016, using the Black-Scholes option valuation model. The weighted-average assumptions used in the Black-Scholes valuation model are reflected in the following table:



	Nine months ended April 30,
Black-Scholes Option Valuation Assumptions	2017		2016
Expected term (in years)	6.11			6.11
Expected volatility	29.55	%		29.95	%
Expected dividend yield	2.70	%		2.59	%
Risk-free interest rate	1.26	%		1.64	%
Weighted-average market value of underlying stock at grant date	$	35.14			$	20.02
Weighted-average exercise price	$	35.14			$	20.02
Weighted-average fair value of options granted during the period	$	7.56			$	4.58

The Company uses historical data regarding stock option exercise behaviors to estimate the expected term of options granted based on the period of time that options granted are expected to be outstanding. Expected volatilities are based on the historical volatility of the Company’s stock. The expected dividend yield is based on the Company’s historical dividend payments and historical yield. The risk-free interest rate is based on the U.S. Treasury yield curve in effect on the grant date for the length of time corresponding to the expected term of the option. The market value is calculated as the average of the high and the low stock price on the date of the grant.

A summary of stock option activity under the Company’s share-based compensation plans for the nine months ended April 30, 2017, is presented below:



Options	Shares	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term	Aggregate Intrinsic Value
Outstanding at July 31, 2016	3,714,039	$	27.34
New grants	378,939	35.14
Exercised	(856,057)	27.68
Forfeited or expired	(304,823)	35.06
Outstanding at April 30, 2017	2,932,098	$	27.44		6.1	$	34,919,577
Exercisable at April 30, 2017	1,882,244	$	28.37		4.8	$	20,664,011

There were 1,882,244 and 2,679,527 options exercisable with a weighted average exercise price of $28.37 and $30.09 at April 30, 2017 and 2016, respectively. The total intrinsic value of options exercised during the nine months ended April 30, 2017 and 2016, based upon the average market price at the time of exercise during the period, was $7,809 and $105, respectively. The total fair value of stock options vested during the nine months ended April 30, 2017 and 2016, was $2,901 and $3,193, respectively.

The cash received from the exercise of options during the three months ended April 30, 2017 and 2016, was $4,015 and $610, respectively. The cash received from the exercise of options during the nine months ended April 30, 2017, and 2016 was $18,674 and $663, respectively. The tax benefit on options exercised during the three months ended April 30, 2017 and 2016, was $1,514 and $37, respectively. The tax benefit on options exercised during the nine months ended April 30, 2017 and 2016, was $2,967 and $40, respectively.

Table of Contents

The following table summarizes the RSU activity under the Company's share-based compensation plans for the nine months ended April 30, 2017:



Service-Based RSUs	Shares		Weighted Average Grant Date Fair Value
Outstanding at July 31, 2016	678,381			$	23.57
New grants	93,355			35.13
Vested	(118,000	)		22.89
Forfeited	(47,235	)		24.35
Outstanding at April 30, 2017	606,501			$	25.42

The service-based RSUs granted during the nine months ended April 30, 2016, had a weighted-average grant date fair value of $20.07. The total fair value of service-based RSUs vested during the nine months ended April 30, 2017 and 2016, was $4,173 and $1,471, respectively.



Performance-Based RSUs	Shares	Weighted Average Grant Date Fair Value
Outstanding at July 31, 2016	—		$	—
New grants	58,206		32.03
Vested	—		—
Forfeited	—		—
Outstanding at April 30, 2017	58,206		$	32.03

No performance-based RSUs were granted during the nine months ended April 30, 2016. The aggregate intrinsic value of unvested service-based and performance-based RSUs outstanding at April 30, 2017, and expected to vest, was $25,890.

Table of Contents

NOTE G — Fair Value Measurements

In accordance with fair value accounting guidance, the Company’s assets and liabilities measured at fair market value are classified in one of the following categories:

Level 1 — Assets or liabilities for which fair value is based on unadjusted quoted prices in active markets for identical instruments that are accessible as of the reporting date.

Level 2 — Assets or liabilities for which fair value is based on other significant pricing inputs that are either directly or indirectly observable.

Level 3 — Assets or liabilities for which fair value is based on significant unobservable pricing inputs to the extent little or no market data is available, which result in the use of management's own assumptions.

The following tables set forth by level within the fair value hierarchy our financial assets and liabilities that were accounted for at fair value on a recurring basis at April 30, 2017 and July 31, 2016, according to the valuation techniques the Company used to determine their fair values.



	Inputs Considered As
	Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Fair Values		Balance Sheet Classifications
April 30, 2017
Trading securities	$	13,795			$	—		$	13,795	Other assets
Foreign exchange contracts	—			900			900		Prepaid expenses and other current assets
Total Assets	$	13,795			$	900		$	14,695
Foreign exchange contracts	$	—			$	308		$	308	Other current liabilities
Total Liabilities	$	—			$	308		$	308
July 31, 2016
Trading securities	$	13,834			$	—		$	13,834	Other assets
Foreign exchange contracts	—			2,138			2,138		Prepaid expenses and other current assets
Total Assets	$	13,834			$	2,138		$	15,972
Foreign exchange contracts	$	—			$	738		$	738	Other current liabilities
Total Liabilities	$	—			$	738		$	738

The following methods and assumptions were used to estimate the fair value of each class of financial instrument:

Trading securities: The Company’s deferred compensation investments consist of investments in mutual funds. These investments were classified as Level 1 as the shares of these investments trade with sufficient frequency and volume to enable us to obtain pricing information on an ongoing basis.

Foreign exchange contracts: The Company’s foreign exchange contracts were classified as Level 2 as the fair value was based on the present value of the future cash flows using external models that use observable inputs, such as interest rates, yield curves and foreign exchange rates. See Note H, “Derivatives and Hedging Activities,” for additional information.

There have been no transfers of assets or liabilities between the fair value hierarchy levels outlined above during the nine months ended April 30, 2017. In addition, the Company had no significant measurements of assets or liabilities at fair value on a nonrecurring basis subsequent to their initial recognition during the nine months ended April 30, 2017.

The Company’s financial instruments, other than those presented in the disclosures above, include cash and cash equivalents, accounts receivable, notes payable, accounts payable, and other liabilities. The fair values of these financial instruments approximated carrying values because of their short-term nature.

The estimated fair value of the Company’s short-term and long-term debt obligations, excluding notes payable, based on the quoted market prices for similar issues and on the current rates offered for debt of similar maturities was $138,778 and $218,977 at April 30, 2017 and July 31, 2016, respectively, as compared to the carrying value of $133,894 and $211,982 at April 30, 2017 and July 31, 2016, respectively.

Table of Contents

NOTE H — Derivatives and Hedging Activities

The Company utilizes forward foreign exchange currency contracts to reduce the exchange rate risk of specific foreign currency denominated transactions. These contracts typically require the exchange of a foreign currency for U.S. dollars at a fixed rate at a future date, with maturities of less than 18 months, which qualify as cash flow hedges or net investment hedges under the accounting guidance for derivative instruments and hedging activities. The primary objective of the Company’s foreign currency exchange risk management program is to minimize the impact of currency movements due to transactions in other than the respective subsidiaries’ functional currency and to minimize the impact of currency movements on the Company’s net investment denominated in a currency other than the U.S. dollar. To achieve this objective, the Company hedges a portion of known exposures using forward foreign exchange currency contracts. As of April 30, 2017 and July 31, 2016, the notional amount of outstanding forward exchange contracts was $131,051 and $186,093, respectively.

The Company hedges a portion of known exposures using forward exchange contracts. Main exposures are related to transactions denominated in the British Pound, the Euro, Canadian Dollar, Australian Dollar, Mexican Peso, and Singapore Dollar. Generally, these risk management transactions will involve the use of foreign currency derivatives to minimize the impact of currency movements on non-functional currency transactions.

Hedge effectiveness is determined by how closely the changes in fair value of the hedging instrument offset the changes in the fair value or cash flows of the hedged item. Hedge accounting is permitted only if the hedging relationship is expected to be highly effective at the inception of the hedge and on an on-going basis. Gains or losses on the derivative related to hedge ineffectiveness are recognized in current earnings.

Cash Flow Hedges

The Company has designated a portion of its foreign exchange contracts as cash flow hedges and recorded these contracts at fair value on the condensed consolidated balance sheets. For these instruments, the effective portion of the gain or loss on the derivative is reported as a component of OCI and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. As of April 30, 2017 and 2016, unrealized gains of $171 and losses of $605 have been included in OCI, respectively. Balances are reclassified from OCI to earnings when the hedged transactions impact earnings. For the three months ended April 30, 2017 and 2016, the Company reclassified losses of $114 and $169 from OCI into earnings, respectively. For the nine months ended April 30, 2017 and 2016, the Company reclassified losses of $530 and gains of $174 from OCI into earnings, respectively. At April 30, 2017, the U.S. dollar equivalent of these outstanding forward foreign exchange contracts totaled $38,662, including contracts to sell Euros, Canadian Dollars, Australian Dollars, and U.S. Dollars.

Net Investment Hedges

The Company has also designated intercompany and third party foreign currency denominated debt instruments as net investment hedges. As of April 30, 2017, £25,036 of intercompany loans were designated as net investment hedges to hedge portions of the Company's net investment in British foreign operations. As of April 30, 2017, €45 million of Euro-denominated senior unsecured notes were designated as net investment hedges to hedge portions of its net investment in European operations. The Company’s foreign denominated debt obligations are valued under a market approach using publicized spot prices.

Non-Designated Hedges

For the three and nine months ended April 30, 2017, the Company recognized gains of $1,725 and losses of $3,321 respectively, in “Investment and other income” on the condensed consolidated statements of earnings related to non-designated hedges. For the three and nine months ended April 30, 2016, the Company recognized gains of $1,410 and $897, respectively.

Table of Contents

Fair values of derivative instruments in the condensed consolidated balance sheets were as follows:



	Asset Derivatives	Liability Derivatives
	April 30, 2017	July 31, 2016		April 30, 2017		July 31, 2016
	Balance Sheet Location	Fair Value		Balance Sheet Location		Fair Value		Balance Sheet Location		Fair Value	Balance Sheet Location	Fair Value
Derivatives designated as hedging instruments
Cash flow hedges
Foreign exchange contracts	Prepaid expenses and other current assets	$	419			Prepaid expenses and other current assets		$	265		Other current liabilities	$	276		Other current liabilities	$	670
Net investment hedges
Foreign currency denominated debt	Prepaid expenses and other current assets	—			Prepaid expenses and other current assets		—			Long term obligations, less current maturities	81,225		Long term obligations, less current maturities	116,888
Total derivatives designated as hedging instruments		$	419					$	265			$	81,501			$	117,558
Derivatives not designated as hedging instruments
Foreign exchange contracts	Prepaid expenses and other current assets	$	481			Prepaid expenses and other current assets		$	1,873		Other current liabilities	$	32		Other current liabilities	$	68
Total derivatives not designated as hedging instruments		$	481					$	1,873			$	32			$	68

NOTE I — New Accounting Pronouncements

In January 2017, the FASB issued ASU 2017-04, \"Goodwill and Other , Simplifying the Test for Goodwill Impairment\" which simplifies the accounting for goodwill impairment. The new guidance removes Step 2 of the goodwill impairment test, which requires a hypothetical purchase price allocation. A goodwill impairment will now be the amount by which a reporting unit’s carrying value exceeds its fair value, not to exceed the carrying amount of goodwill. All other goodwill impairment guidance will remain largely unchanged. This guidance is effective for annual periods beginning after December 15, 2019, and interim periods thereafter; however early adoption is permitted for any impairment tests performed after January 1, 2017. This guidance will only impact the Consolidated Financial Statements if there is a future impairment of goodwill.

In February 2016, the FASB issued ASU 2016-02, \"Leases,\" which replaces the current lease accounting standard. The update will require, among other items, lessees to recognize the assets and liabilities that arise from most leases on the balance sheet. This guidance is effective for annual periods beginning after December 15, 2018, and interim periods within those annual periods. The ASU must be adopted using a modified retrospective approach and early adoption is permitted. The Company is currently evaluating the impact of this update on its consolidated financial statements and disclosures.

In May 2014, the FASB issued ASU 2014-09, \"Revenue from Contracts with Customers,\" which eliminates the transaction-and industry-specific revenue recognition guidance under current GAAP and replaces it with a principles-based approach for determining revenue recognition. The new guidance requires revenue recognition when control of the goods or services transfers to the customer, replacing the existing guidance which requires revenue recognition when the risks and rewards transfer to the customer.

ASU 2014-09 (and related updates) is effective for annual periods beginning after December 15, 2017, and interim periods within those annual periods, with early adoption permitted for annual periods beginning after December 15, 2016. The Company intends to adopt this standard beginning August 1, 2018. Entities have the option of using either a full retrospective or a modified retrospective approach for the adoption of the standard. The Company is currently assessing the new guidance and whether to adopt using a full retrospective or a modified retrospective approach. Management is conducting surveys of its various business units and analyzing contracts and agreements during fiscal 2017 to ensure that all components of the new guidance are appropriately considered for the impact on its consolidated financial statements and disclosures upon adoption.

Table of Contents

NOTE J — Subsequent Events

On May 24, 2017, the Board of Directors declared a quarterly cash dividend to shareholders of the Company’s Class A and Class B Common Stock of $0.205 per share payable on July 31, 2017, to shareholders of record at the close of business on July 10, 2017.

Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF RESULTS OF OPERATIONS AND FINANCIAL CONDITION

Overview

Brady Corporation is a global manufacturer and supplier of identification solutions and workplace safety products that identify and protect premises, products and people. The IDS segment is primarily involved in the design, manufacture, and distribution of high-performance and innovative identification and healthcare products. The WPS segment provides workplace safety and compliance products, half of which are internally manufactured and half are externally sourced. Approximately 45% of our total sales are derived outside of the United States. Foreign sales within the IDS and WPS segments are approximately 40% and 70%, respectively.

The ability to provide customers with a vast array of proprietary, customized and diverse products for use in various applications across multiple customers and geographies, along with a commitment to quality and service, have made Brady a leader in many of its markets. The long-term sales growth and profitability of our segments will depend not only on improved demand in end markets and the overall economic environment, but also on our ability to continuously improve operational excellence, focus on the customer, develop and market innovative new products, and to advance our digital capabilities. In our IDS business, our strategy for growth includes an increased focus on key customers, industries and products and improving the efficiency and effectiveness of the research and development (\"R&D\") function. In our WPS business, our strategy for growth includes a focus on workplace safety critical industries, innovative new product offerings, and increased investment in digital capabilities.

The Company is targeting the following key initiatives in fiscal 2017:


•	Enhancing our innovation development process and the speed to deliver high-value, innovative products that align with our target markets.


•	Driving operational excellence and providing our customers with the highest level of customer service.


•	Performing comprehensive product reviews to optimize our product offerings.


•	Expanding our digital presence with a heightened focus on mobile technologies.


•	Growing through focused sales and marketing efforts in selected vertical markets and strategic accounts.


•	Enhancing our global employee development process to attract and retain key talent.

Results of Operations

A comparison of results of operating income for the three and nine months ended April 30, 2017 and 2016, is as follows:



	Three months ended April 30,		Nine months ended April 30,
(Dollars in thousands)	2017		% Sales		2016		% Sales		2017		% Sales		2016		% Sales
Net Sales	$	275,927					$	286,816					$	824,104				$	838,519
Gross Margin	139,909			50.7	%		145,443			50.7	%		414,425			50.3	%	417,684		49.8	%
Operating Expenses:
Research and Development	9,950			3.6	%		8,865			3.1	%		28,577			3.5	%	26,531		3.2	%
Selling, General and Administrative	98,409			35.7	%		105,794			36.9	%		291,128			35.3	%	306,678		36.6	%
Total operating expenses	108,359			39.3	%		114,659			40.0	%		319,705			38.8	%	333,209		39.7	%
Operating Income	$	31,550			11.4	%		$	30,784			10.7	%		$	94,720		11.5	%	$	84,475	10.1	%

References in this Form 10-Q to “organic sales” refer to sales calculated in accordance with U.S. GAAP, excluding the impact of foreign currency translation. The Company's organic sales disclosures exclude the effects of foreign currency translation as foreign currency translation is subject to volatility that can obscure underlying business trends. Management believes that the non-GAAP financial measure of organic sales is meaningful to investors as it provides them with useful information to aid in identifying underlying sales trends in our businesses and facilitating comparisons of our sales performance with prior periods.

Table of Contents

Sales for the three months ended April 30, 2017, decreased 3.8% to $275.9 million, compared to $286.8 million in the same period of the prior year, which consisted of an organic sales decline of 1.9% and a negative currency impact of 1.9% due to the strengthening of the U.S. Dollar against certain other currencies. Organic sales declined 0.8% in the IDS segment and 4.6% in the WPS segment during the three months ended April 30, 2017, compared to the same period in the prior year. The IDS segment experienced sales declines in the Healthcare ID product line, partially offset by sales growth in the Product ID and Wire ID product lines compared to the prior year. Catalog sales in the WPS segment declined, but were partially offset by sales growth in the digital channel.

Sales for the nine months ended April 30, 2017, decreased 1.7% to $824.1 million, compared to $838.5 million in the same period of the prior year, which consisted of an organic sales decline of 0.3% and a negative currency impact of 1.4%. Organic sales grew 0.6% in the IDS segment and declined 2.5% in the WPS segment during the nine months ended April 30, 2017, compared to the same period in the prior year. The IDS segment realized sales growth in the Product ID and Wire ID product lines, partially offset by sales declines in the Safety and Facility ID product line. Catalog sales in the WPS segment declined, but were partially offset by sales growth in the digital channel.

Gross margin for the three months ended April 30, 2017, declined 3.8% to $139.9 million, compared to $145.4 million in the same period of the prior year, and declined 0.8% to $414.4 million for the nine months ended April 30, 2017, compared to $417.7 million in the same period of the prior year. As a percentage of sales, gross margin remained flat at 50.7% for the three months ended April 30, 2017 compared to the same period of the prior year, and increased to 50.3% for the nine months ended April 30, 2017, from 49.8% in the same period of the prior year. The increase in gross margin percentage during the nine-month period was primarily due to our on-going efforts to streamline manufacturing processes and drive operational efficiencies in manufacturing facilities. These efforts resulted in reduced material, supplies and labor costs compared to the same periods in the prior year.

R&D expenses for the three months ended April 30, 2017, increased 12.2% to $10.0 million, compared to $8.9 million in the same period of the prior year, and increased 7.7% to $28.6 million for the nine months ended April 30, 2017, compared to $26.5 million in the same period of the prior year. The increases in both the three and nine-month periods were due to the hiring of engineers as well as increased spending on printing and software solutions projects within our IDS businesses.

Selling, general and administrative expenses (\"SG&A\") include selling costs directly attributed to the IDS and WPS segments, as well as certain other expenses including finance, information technology, human resources, and other administrative expenses. SG&A decreased 7.0% to $98.4 million for the three months ended April 30, 2017, and 5.1% to $291.1 million for the nine months ended April 30, 2017, compared to $105.8 million and $306.7 million in the same periods of the prior year, respectively. The declines in both the three and nine-month periods were primarily due to reductions in general and administrative costs due to ongoing efficiency gains, as well as foreign currency translation.

Operating income was $31.6 million during the three months ended April 30, 2017, compared to $30.8 million for the three months ended April 30, 2016. Operating income was $94.7 million during the nine months ended April 30, 2017, compared to $84.5 million for the nine months ended April 30, 2016. The increase was primarily due to reduced general and administrative expense in both the IDS and WPS segments, partially offset by the negative impact of foreign currency fluctuations and increased R&D expense in 2017.

OPERATING INCOME TO NET EARNINGS



	Three months ended April 30,		Nine months ended April 30,
(Dollars in thousands)	2017		% Sales		2016		% Sales		2017		% Sales		2016		% Sales
Operating income	$	31,550			11.4	%		$	30,784			10.7	%		$	94,720		11.5	%	$	84,475	10.1	%
Other income (expense):
Investment and other income (expense)	453			0.2	%		721			0.3	%		560			0.1	%	(1,030	)	(0.1	)%
Interest expense	(1,375	)		(0.5	)%		(1,838	)		(0.6	)%		(4,565	)		(0.6	)%	(6,119	)	(0.7	)%
Earnings before income tax	30,628			11.1	%		29,667			10.3	%		90,715			11.0	%	77,326		9.2	%
Income tax expense	8,075			2.9	%		8,686			3.0	%		20,312			2.5	%	22,352		2.7	%
Net earnings	$	22,553			8.2	%		$	20,981			7.3	%		$	70,403		8.5	%	$	54,974	6.6	%

Table of Contents

Investment and other income was $0.5 million for the three months ended April 30, 2017, which was consistent with the prior year of $0.7 million. Investment and other income was $0.6 million for the nine months ended April 30, 2017, compared to investment and other expense of $1.0 million in the same period of the prior year. The increase in income in the current nine-month period was primarily due to an increase in the market value of securities held in executive deferred compensation plans.

Interest expense decreased to $1.4 million from $1.8 million for the three months, and decreased to $4.6 million from $6.1 million for the nine months ended April 30, 2017, compared to the same periods in the prior year. For both the three and nine-month periods, the decrease was due to a reduction in the Company's outstanding debt balances.

The Company’s income tax rate was 26.4% for the three months ended April 30, 2017, compared to 29.3% for the same period in the prior year. The income tax rate was 22.4% for the nine months ended April 30, 2017, compared to 28.9% for the same period of the prior year. The decrease in the income tax rate for the three months ended April 30, 2017 was primarily due to a decrease in the reserve in uncertain tax positions compared to the same period of the prior year. The decrease in the income tax rate for the nine months ended April 30, 2017, was primarily due to foreign tax credits generated from a cash repatriation to the U.S. that occurred during the Company's second fiscal quarter. The Company's anticipated annual income tax rate is expected to be in the mid-20% range for fiscal year 2017.

Table of Contents

Business Segment Operating Results

The Company is organized and managed on a global basis within two reportable segments: ID Solutions and Workplace Safety. Effective August 1, 2016, the Company changed its internal measure of segment profit and loss that is reported to the chief operating decision maker for purposes of making decisions about allocating resources to the segment and assessing its performance. Prior to August 1, 2016, administrative costs were excluded from the measure of segment profit and loss. Effective August 1, 2016, a portion of these administrative costs have been included within the IDS and WPS segments, which includes the cost of finance, information technology, human resources, and certain other administrative costs. Interest expense, investment and other income (expense), income tax expense, and certain corporate administrative expenses continue to be excluded when evaluating segment performance.

The following is a summary of segment information for the three and nine months ended April 30, 2017, and 2016:



	Three months ended April 30,		Nine months ended April 30,
(Dollars in thousands)	2017		2016		2017		2016
SALES TO EXTERNAL CUSTOMERS
ID Solutions	$	196,880			$	201,482			$	589,106		$	592,282
Workplace Safety	79,047			85,334			234,998			246,237
Total	$	275,927			$	286,816			$	824,104		$	838,519
SALES GROWTH INFORMATION
ID Solutions
Organic	(0.8	)%		(0.9	)%		0.6	%		(0.8	)%
Currency	(1.5	)%		(1.1	)%		(1.1	)%		(3.7	)%
Total	(2.3	)%		(2.0	)%		(0.5	)%		(4.5	)%
Workplace Safety
Organic	(4.6	)%		1.7	%		(2.5	)%		(0.4	)%
Currency	(2.9	)%		(0.9	)%		(2.1	)%		(6.0	)%
Total	(7.5	)%		0.8	%		(4.6	)%		(6.4	)%
Total Company
Organic	(1.9	)%		(0.1	)%		(0.3	)%		(0.7	)%
Currency	(1.9	)%		(1.1	)%		(1.4	)%		(4.3	)%
Total	(3.8	)%		(1.2	)%		(1.7	)%		(5.0	)%
SEGMENT PROFIT
ID Solutions	$	32,633			$	31,898			$	94,676		$	80,385
Workplace Safety	5,120			6,012			17,615			21,690
Total	$	37,753			$	37,910			$	112,291		$	102,075
SEGMENT PROFIT AS A PERCENT OF SALES
ID Solutions	16.6	%		15.8	%		16.1	%		13.6	%
Workplace Safety	6.5	%		7.0	%		7.5	%		8.8	%
Total	13.7	%		13.2	%		13.6	%		12.2	%

Table of Contents

The following is a reconciliation of segment profit to earnings before income taxes for the three and nine months ended April 30, 2017 and 2016:



	Three months ended April 30,		Nine months ended April 30,
	2017		2016		2017		2016
Total profit from reportable segments	$	37,753			$	37,910			$	112,291		$	102,075
Unallocated amounts:
Administrative costs	(6,203	)		(7,126	)		(17,571	)		(17,600	)
Investment and other income (expense)	453			721			560			(1,030	)
Interest expense	(1,375	)		(1,838	)		(4,565	)		(6,119	)
Earnings before income taxes	$	30,628			$	29,667			$	90,715		$	77,326

ID Solutions

Approximately 70% of net sales in the IDS segment were generated in the Americas region, 20% in Europe and 10% in Asia. IDS sales decreased 2.3% to $196.9 million for the three months ended April 30, 2017, compared to $201.5 million for the same period in the prior year, which consisted of an organic sales decline of 0.8% and a negative currency impact of 1.5%. IDS sales decreased 0.5% to $589.1 million for the nine months ended April 30, 2017, compared to $592.3 million for the same period in the prior year. Organic sales increased 0.6% and currency fluctuations decreased sales by 1.1% during the nine months ended April 30, 2017.

Organic sales in the Americas declined in the low-single digits for the three months ended April 30, 2017, and were essentially flat for the nine months ended April 30, 2017, compared to the same periods in the prior year. The decrease in organic sales during the three-month period was primarily due to pricing pressure from certain distributors in the Healthcare ID product line, partially offset by sales growth in the Wire ID product line. Flat organic sales in the IDS Americas region for the nine-month period was primarily due to sales growth in the Wire ID product line due to an increase in sales of printer consumables, offset by a decline in sales in the Healthcare ID and Product ID product lines. An organic sales decline in the United States was partially offset by organic sales growth in Mexico and Canada for both the three and nine-month periods.

The IDS business in Europe had essentially flat organic sales for the three months ended April 30, 2017, and realized low-single digit organic sales growth for the nine months ended April 30, 2017, compared to the same periods in the prior year. The IDS Europe region realized organic sales growth in the Safety and Facility ID product line, offset by organic sales declines in the Product ID and Wire ID product lines for the three months ended April 30, 2017, compared to the same period in the prior year. Organic sales grew in the low-single digits for the nine months ended April 30, 2017, compared to the same period in the prior year. Organic sales growth for the nine months ended April 30, 2017, was primarily due to sales increases in the Product ID and Safety and Facility ID product lines, compared to the same period in the prior year. Organic sales growth in western Europe was partially offset by organic sales declines in certain emerging markets due to weak demand in the oil and gas industry.

Organic sales in Asia grew in the low-double digits for the three months ended April 30, 2017, and mid-single digits for the nine months ended April 30, 2017, compared to the same periods in the prior year. The IDS Asia region realized organic sales growth in the OEM and MRO product categories for the three months ended April 30, 2017, compared to the same period in the prior year. Organic sales for the nine months ended April 30, 2017, grew in the OEM product category and were essentially flat in the MRO product category, compared to the same period in the prior year. Organic sales increased within all countries in the Asia region for both the three and nine-month periods.

Segment profit increased to $32.6 million for the three months ended April 30, 2017, compared to $31.9 million in the same period in the prior year. As a percentage of sales, segment profit increased to 16.6% from 15.8% in the same period in the prior year. Segment profit increased to $94.7 million from $80.4 million for the nine months ended April 30, 2017, compared to the same period in the prior year. As a percentage of sales, segment profit increased to 16.1% from 13.6% for same period in the prior year. The increase in segment profit for both the three and nine-month periods was primarily driven by operational efficiencies in our manufacturing processes in all regions, as well as a reduction in SG&A due to ongoing process improvement activities.

Table of Contents

WPS

Approximately 50% of net sales in the WPS segment were generated in Europe, 35% in the Americas and 15% in Australia. WPS sales decreased 7.5% to $79.0 million for the three months and 4.6% to $235.0 million for the nine months ended April 30, 2017, compared to $85.3 million and $246.2 million, respectively, for the same periods in the prior year. Organic sales declined 4.6% and 2.5% in the three and nine months ended April 30, 2017, respectively, compared to the same periods in the prior year. Currency fluctuations decreased sales by 2.9% and 2.1% for the three and nine months ended April 30, 2017, respectively, due to the strengthening of the U.S. dollar against certain other major currencies as compared to the same periods in the prior year.

Organic sales in Europe were essentially flat for the three months ended April 30, 2017, and increased in the low-single digits for the nine months ended April 30, 2017, compared to the same periods in the prior year. The growth in the nine-month period was driven primarily by Germany, France, and Belgium due to improvements in website functionality and key account management. Digital sales growth in the Europe region was in the high-single digits for the three-month period and double-digits for the nine-month period, compared to the same periods in the prior year.

Organic sales in the Americas declined in the high-single digits during the three and nine months ended April 30, 2017, compared to the same periods in the prior year. This decrease was primarily in the U.S. due to lower response rates to catalog promotions and continued pricing pressures in industrial end markets. In addition, pricing pressures from certain competitors have led to an acceleration of organic sales declines in the region from prior quarters.

Organic sales in Australia declined in the mid-single digits for the three months ended April 30, 2017, and declined in the low-single digits for the nine months ended April 30, 2017, compared to the same periods in the prior year. The organic sales declines in Australia were due to its higher concentration in industries that are experiencing economic challenges, which include manufacturing and mining production.

Segment profit decreased to $5.1 million from $6.0 million for the three months, and to $17.6 million from $21.7 million for the nine months ended April 30, 2017, compared to the same periods in the prior year. As a percentage of sales, segment profit decreased to 6.5% from 7.0% for the three months, and to 7.5% from 8.8% for the nine months ended April 30, 2017, compared to the same periods in the prior year. The decrease in segment profit was primarily due to the decline in sales and compressed gross profit margins partially due to pricing, which was partially offset by reduced selling, general and administrative expenses.

Financial Condition

Cash and cash equivalents decreased by $12.2 million and increased by $27.1 million during the nine months ended April 30, 2017 and 2016, respectively. The significant changes were as follows:



	Nine months ended April 30,
(Dollars in thousands)	2017		2016
Net cash flow provided by (used in):
Operating activities	$	91,162			$	98,550
Investing activities	(10,818	)		(5,481	)
Financing activities	(89,986	)		(69,228	)
Effect of exchange rate changes on cash	(2,509	)		3,263
Net (decrease) increase in cash and cash equivalents	$	(12,151	)		$	27,104

Net cash provided by operating activities was $91.2 million for the nine months ended April 30, 2017, compared to $98.6 million in the same period of the prior year. The decrease in cash provided by operating activities of $7.4 million was primarily due to a decrease in cash provided by working capital. The change in the cash outflow from accounts receivable of $5.6 million was primarily due to the timing of sales in the U.S. and Western Europe compared to the prior year. The prior year cash inflow from inventory of $4.6 million was due to declines following the build-up of inventories in prior years in anticipation of facility consolidation activities. These current year uses of cash for working capital were partially offset by an increase in net earnings.

Net cash used in investing activities was $10.8 million for the nine months ended April 30, 2017, compared to $5.5 million in the same period of the prior year. The increase in cash used in investing activities of $5.3 million was primarily due to an increase in capital expenditures due to the purchase of manufacturing equipment and facility upgrades in the United States and Europe.

Net cash used in financing activities was $90.0 million during the nine months ended April 30, 2017, compared to $69.2 million in the same period of the prior year. The increase in cash used in financing activities of $20.8 million was primarily due

Table of Contents

to an increase of $63.1 million in credit facility and debt repayments in the current year, which was partially offset by an $18.0 million increase in proceeds from stock option exercises in the current year. The remainder of the change was due to $23.6 million of cash used for share repurchases in the prior year, while no shares were repurchased in the current year.

The effect of fluctuations in exchange rates decreased cash balances by $2.5 million primarily due to cash balances held in currencies that depreciated against the U.S. dollar during nine months ended April 30, 2017.

On May 13, 2010, the Company completed a private placement of €75 million aggregate principal amount of senior unsecured notes to institutional investors. The €75 million of senior notes consists of €30 million aggregate principal amount of 3.71% Series 2010-A Senior Notes, due May 13, 2017 and €45 million aggregate principal amount of 4.24% Series 2010-A Senior Notes, due May 13, 2020, with interest payable on the notes semiannually. The notes have certain prepayment penalties for repaying them prior to maturity. The Company intends to utilize its revolving credit facility to fund private placement principal payments due during the fiscal year ended July 31, 2017, and therefore the maturities are included in \"Long-term obligations, less current maturities\" on the condensed consolidated balance sheets as of April 30, 2017.

On September 25, 2015, the Company and certain of its subsidiaries entered into an unsecured $300 million multi-currency revolving loan agreement with a group of six banks that replaced and terminated the Company’s previous loan agreement that had been entered into on February 1, 2012. Under the new revolving loan agreement, which has a final maturity date of September 25, 2020, the Company has the option to select either a base interest rate (based upon the higher of the federal funds rate plus one-half of 1%, the prime rate of Bank of America plus a margin based on the Company’s consolidated leverage ratio, or the one month LIBOR rate plus 1%) or a Eurocurrency interest rate (at the LIBOR rate plus a margin based on the Company’s consolidated leverage ratio). At the Company's option, and subject to certain conditions, the available amount under the revolving loan agreement may be increased from $300 million to $450 million. During the nine months ended April 30, 2017, the Company repaid $59.6 million on the revolving loan agreement. As of April 30, 2017, the outstanding balance on the credit facility was $52.4 million, and the maximum outstanding balance during the nine months ended April 30, 2017 was $112 million. The Company also had letters of credit outstanding under the loan agreement of $4.1 million as of April 30, 2017, and there was $243.4 million available for future borrowing, which can be increased to $393.4 million at the Company's option, subject to certain conditions. The revolving loan agreement has a final maturity date of September 25, 2020. As such, the borrowing is included in \"Long-term obligations, less current maturities\" on the condensed consolidated balance sheets.

The Company has two multi-currency lines of credit in China with capacity of $10 million each. These lines of credit support USD-denominated or CNY-denominated borrowing to fund working capital and operations for the Company's Chinese entities and are due on demand. The borrowings under these facilities may be made for a period up to one year from the date of borrowing with interest on the USD-denominated borrowings incurred equal to U.S. dollar LIBOR on the date of borrowing plus a margin based upon duration and on the CNY-denominated borrowings incurred equal to the local China rate based upon duration. There is no ultimate maturity on the facilities and they are subject to periodic review and repricing. The Company is not required to comply with any financial covenants as part of the agreements. During the nine months ended April 30, 2017, the Company repaid $0.9 million of these multi-currency lines of credit and the maximum outstanding balance was $5.7 million. As of April 30, 2017, the aggregate outstanding balance of these lines was $4.1 million. There was $14.3 million available for future borrowing under these facilities as of April 30, 2017. Due to the short-term nature of these credit facilities, the borrowings are classified as \"Notes payable\" within current liabilities on the condensed consolidated balance sheets.

The Company’s debt agreements require it to maintain certain financial covenants, including a ratio of debt to the trailing twelve months EBITDA, as defined in the debt agreements, of not more than a 3.25 to 1.0 ratio (leverage ratio) and the trailing twelve months EBITDA to interest expense of not less than a 3.0 to 1.0 ratio (interest expense coverage). As of April 30, 2017, the Company was in compliance with these financial covenants, with the leverage ratio, as defined by the agreements, equal to 0.9 to 1.0 and the interest expense coverage ratio equal to 26.5 to 1.0.

The Company's cash balances are generated and held in numerous locations throughout the world. At April 30, 2017, approximately 76% of the Company's cash and cash equivalents were held outside the United States. The Company's growth has historically been funded by a combination of cash provided by operating activities and debt financing. The Company believes that its cash flow from operating activities, in addition to its borrowing capacity, are sufficient to fund its anticipated requirements for working capital, capital expenditures, common stock repurchases, scheduled debt repayments, and dividend payments for the next 12 months. Although we believe these sources of cash are currently sufficient to fund our domestic operations, our annual cash needs could require us to repatriate cash to the U.S. from foreign jurisdictions, which may result in tax charges.

Table of Contents

Subsequent Events

Off-Balance Sheet Arrangements

The Company does not have material off-balance sheet arrangements. The Company is not aware of factors that are reasonably likely to adversely affect liquidity trends, other than the risk factors described in this and other Company filings. However, the following additional information is provided to assist those reviewing the Company’s financial statements.

Operating Leases - The leases generally are entered into for investments in facilities such as manufacturing facilities, warehouses and office space, computer equipment and Company vehicles.

Purchase Commitments - The Company has purchase commitments for materials, supplies, services, and property, plant and equipment as part of the ordinary conduct of its business. In the aggregate, such commitments are not in excess of current market prices and are not material to the financial position of the Company. Due to the proprietary nature of many of the Company’s materials and processes, certain supply contracts contain penalty provisions for early termination. The Company does not believe a material amount of penalties will be incurred under these contracts based upon historical experience and current expectations.

Other Contractual Obligations - The Company does not have material financial guarantees or other contractual commitments that are reasonably likely to adversely affect liquidity.

Forward-Looking Statements

In this quarterly report on Form 10-Q, statements that are not reported financial results or other historic information are “forward-looking statements.” These forward-looking statements relate to, among other things, the Company's future financial position, business strategy, targets, projected sales, costs, earnings, capital expenditures, debt levels and cash flows, and plans and objectives of management for future operations.

The use of words such as “may,” “will,” “expect,” “intend,” “estimate,” “anticipate,” “believe,” “should,” “project” or “plan” or similar terminology are generally intended to identify forward-looking statements. These forward-looking statements by their nature address matters that are, to different degrees, uncertain and are subject to risks, assumptions, and other factors, some of which are beyond Brady's control, that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. For Brady, uncertainties arise from:


•	Brady's ability to compete effectively or to successfully execute our strategy


•	Brady's ability to develop technologically advanced products that meet customer demands


•	Difficulties in protecting our websites, networks, and systems against security breaches


•	Deterioration or instability in the global economy and financial markets


•	Decreased demand for the Company's products


•	Brady's ability to retain large customers


•	Risks associated with the loss of key employees


•	Changes in tax legislation and tax rates


•	Brady's ability to execute facility consolidations and maintain acceptable operational service metrics


•	Extensive regulations by U.S. and non-U.S. governmental and self regulatory entities


•	Litigation, including product liability claims


•	Divestitures and contingent liabilities from divestitures


•	Brady's ability to properly identify, integrate, and grow acquired companies


•	Foreign currency fluctuations


•	Potential write-offs of Brady's substantial intangible assets


•	Differing interests of voting and non-voting shareholders


•	Brady's ability to meet certain financial covenants required by our debt agreements.

•

Numerous other matters of national, regional and global scale, including those of a political, economic, business, competitive, and regulatory nature contained from time to time in Brady's U.S. Securities and Exchange Commission filings, including, but not limited to, those factors listed in the “Risk Factors” section within Item 1A of Part I of the Form 10-K filed with the SEC on September 15, 2016.

These uncertainties may cause Brady's actual future results to be materially different than those expressed in its forward-looking statements. Brady does not undertake to update its forward-looking statements except as required by law.

Table of Contents

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Refer to the Company’s annual report on Form 10-K for the year ended July 31, 2016. There has been no material change in this information since July 31, 2016.

ITEM 4. CONTROLS AND PROCEDURES

Brady Corporation maintains a set of disclosure controls and procedures that are designed to ensure that information required to be disclosed by the Company in the reports filed by the Company under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by the Company in the reports the Company files under the Exchange Act is accumulated and communicated to the Company’s management, including the Company’s principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. The Company carried out an evaluation, under the supervision and with the participation of its management, including its President and Chief Executive Officer and its Chief Financial Officer and Treasurer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures pursuant to Rule 13a-15 of the Exchange Act. Based on that evaluation, the Company’s President and Chief Executive Officer and Chief Financial Officer and Treasurer concluded that the Company’s disclosure controls and procedures are effective as of the end of the period covered by this report.

There were no significant changes in the Company's internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) that occurred during the Company's most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

Table of Contents

PART II. OTHER INFORMATION

ITEM 6. EXHIBITS


(a)	Exhibits



31.1	Rule 13a-14(a)/15d-14(a) Certification of J. Michael Nauman

31.2	Rule 13a-14(a)/15d-14(a) Certification of Aaron J. Pearce

32.1	Section 1350 Certification of J. Michael Nauman

32.2	Section 1350 Certification of Aaron J. Pearce

101	Interactive Data File

Table of Contents

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

SIGNATURES



						BRADY CORPORATION

Date: May 25, 2017						/s/ J. MICHAEL NAUMAN
						J. Michael Nauman
						President and Chief Executive Officer
						(Principal Executive Officer)


Date: May 25, 2017						/s/ AARON J. PEARCE
						Aaron J. Pearce
						Chief Financial Officer and Treasurer
						(Principal Financial Officer)

\t\n\n

\n\n\t\n\t\t\n\t\t\n\t\tExhibit\n\t\n\t\n

EXHIBIT 31.1

RULE 13a-14(a)/15d-14(a) CERTIFICATION

I, J. Michael Nauman, certify that:

(1) I have reviewed this quarterly report on Form 10-Q of Brady Corporation;

(2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material act necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

(3) Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

(4) I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision to provided reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

(5) I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.




Date: May 25, 2017

/s/ J. MICHAEL NAUMAN
President and Chief Executive Officer
(Principal Executive Officer)

\t\n\n

\n\n\t\n\t\t\n\t\t\n\t\tExhibit\n\t\n\t\n

EXHIBIT 31.2

RULE 13a-14(a)/15d-14(a) CERTIFICATION

I, Aaron J. Pearce, certify that:

(1) I have reviewed this quarterly report on Form 10-Q of Brady Corporation;

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.




Date: May 25, 2017

/s/ AARON J. PEARCE
Chief Financial Officer and Treasurer
(Principal Financial Officer)

\t\n\n

\n\n\t\n\t\t\n\t\t\n\t\tExhibit\n\t\n\t\n

EXHIBIT 32.1

SECTION 1350 CERTIFICATION

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Brady Corporation (the “Company”) certifies to his knowledge that:

(1) The Quarterly Report on Form 10-Q of the Company for the quarterly period ended April 30, 2017 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in that Form 10-Q fairly presents, in all material respects, the financial conditions and results of operations of the Company.




Date: May 25, 2017

/s/ J. MICHAEL NAUMAN
President and Chief Executive Officer
(Principal Executive Officer)

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request. This certification accompanies this report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

\t\n\n

\n\n\t\n\t\t\n\t\t\n\t\tExhibit\n\t\n\t\n

EXHIBIT 32.2

SECTION 1350 CERTIFICATION

(2) The information contained in that Form 10-Q fairly presents, in all material respects, the financial conditions and results of operations of the Company.




Date: May 25, 2017

/s/ AARON J. PEARCE
Chief Financial Officer and Treasurer
(Principal Financial Officer)

\t\n\n","error":null}